Available NOW: New Tumor-associated PepMix Peptide Pools!
Published on 15/06/2023
Tumor associated antigens (TAAs) are expressed by tumor cells and recognizable by the host's immune system; either via immune cells or antibodies. We provide the most comprehensive portfolio of peptide products and services for working with immune cells in cancer immunotherapy & vaccine development. With our purified PepMix Peptide Pools, you are able to stimulate antigen-specific CD4+ and CD8+ T cells in a robust, accurate and reproducible fashion.
We continuously aim to update our ready-to-use PepMix Peptide Pools covering tumor-associated antigens, involved in cell proliferation, oncogene regulation, melanin synthesis and more.
Our PepMix portfolio covers more than 50 different human TAA PepMixes!
NEW TAA PepMix Peptide Pools:
- Human Melanoma-associated antigen A2
- Human Melanoma-associated antigen C2
- Human Tyrosinase-related protein 1
- Human NY-ESO-2 (cancer/testis antigen 6.2)
- Human SSX4 (cancer/testis antigen 5.4)
- Human KRAS
Have a look at the complete list of tumor-associated antigen PepMixes.